scholarly article | Q13442814 |
P356 | DOI | 10.1097/TP.0B013E3181949D4E |
P698 | PubMed publication ID | 19307793 |
P50 | author | Suchitra Sumitran-Holgersson | Q50818166 |
Winfred W Williams | Q106399791 | ||
P2093 | author name string | Ronald Pelletier | |
Andrea A Zachary | |||
Susan L Saidman | |||
Annette M Jackson | |||
Jan Holgersson | |||
Michael E Breimer | |||
Lennart Rydberg | |||
Gunnar Tydén | |||
Per Grufman | |||
Jon Von Visger | |||
Donna P Lucas | |||
Joseph K Melancon | |||
Göran K Klintmalm | |||
Sonnya Coultrup | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 549-556 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation | |
P478 | volume | 87 |
Q37425991 | Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient |
Q38818993 | Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside |
Q37676032 | Advances in diagnosing and managing antibody-mediated rejection |
Q43865301 | Antibodies beyond HLA. |
Q28076193 | Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation |
Q38169496 | Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. |
Q38131035 | Assessing immunologic risk factors in transplantation |
Q37742103 | Barriers to successful transplantation of the sensitized patient |
Q46053824 | Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles |
Q35832457 | Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts |
Q38891100 | Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma? |
Q91655429 | Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort |
Q37836967 | Current approaches to the management of highly sensitized kidney transplant patients |
Q82082999 | De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection |
Q47839666 | Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury |
Q92235464 | Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens |
Q35550551 | Endothelial cell antibodies associated with novel targets and increased rejection |
Q48324851 | Endothelial precursor cell cross-match using Tie-2-enriched spleen cells. |
Q83841650 | Flow cytometric crossmatching and panel-reactive antibodies in chronic renal failure patients |
Q36584523 | HLA and MICA: targets of antibody-mediated rejection in heart transplantation. |
Q38246582 | Humoral immunity and complement effector mechanisms after lung transplantation |
Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
Q35574493 | IgM antibodies towards pre-endothelial cells: strong indication for an association with accelerated rejection. A case report |
Q37681362 | Immunogenetics and immunology in transplantation |
Q37660263 | Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy |
Q33661464 | Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation. |
Q37854488 | Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch? |
Q38597010 | Mechanisms underlying human genetic diversity: consequence for anti-graft antibody responses. |
Q38123310 | Moving beyond HLA: a review of nHLA antibodies in organ transplantation |
Q83493021 | Non-HLA antibodies in kidney allograft rejection: convincing concept in need of further evidence |
Q34259047 | Non-MHC antigenic targets of the humoral immune response in transplantation |
Q85843781 | Noninvasive allograft imaging of acute rejection: evaluation of (131)I-anti-CXCL10 mAb |
Q37637948 | Noninvasive diagnosis of acute rejection of renal allografts |
Q38019584 | Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review |
Q38510983 | Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies |
Q45903936 | Replacement of a tracheal stenosis with a tissue-engineered human trachea using autologous stem cells: a case report. |
Q37313051 | Report from a consensus conference on antibody-mediated rejection in heart transplantation |
Q38877375 | The importance of non-HLA antibodies in transplantation |
Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
Q27024077 | Vascular endothelium as a target of immune response in renal transplant rejection |
Q93074073 | WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint] |
Search more.